Proteome Sciences plc (LON:PRM – Get Free Report) traded down 15.1% during mid-day trading on Tuesday . The company traded as low as GBX 2.35 ($0.03) and last traded at GBX 2.35 ($0.03). 343,488 shares traded hands during trading, an increase of 117% from the average session volume of 158,279 shares. The stock had previously closed at GBX 2.77 ($0.04).
Proteome Sciences Price Performance
The company’s 50-day moving average price is GBX 2.87 and its 200-day moving average price is GBX 3.33. The company has a market cap of £6.95 million, a P/E ratio of -260.00 and a beta of 0.07.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Articles
- Five stocks we like better than Proteome Sciences
- What is the Australian Securities Exchange (ASX)
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Applied Materials Market Capitulates: Now is the Time to Buy
- Following Congress Stock Trades
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
